TELOPEPTIDES OF TYPE II COLLAGEN BINDING TO HUMAN ANKLE CHONDROCYTES

A. Cole
Abstract:INTRODUCTION: Type II collagen, a major component of cartilage, consists of a triple helical domain along with N and C non-helical domains. Various enzymes can generate a variety of naturally occurring fragments. Matrix metalloproteinase – 3 is known to cleave type II collagen within the N-telopeptide; this cleavage releases N-telopeptide and in the process disturbs the fibrous network. Annexin-V, a 34-kDa protein, can bind intact type II collagen and the N-telopeptide. Unique genes encode Annexin family and they exhibit a wide range of functions including cell-matrix interaction, calcium ion channeling and signal transduction. Protein Kinase C (PKC) is one of the kinases that is involved in the cell-matrix interaction as well as signal transduction. The activation of PKC by influx of calcium is also linked to the reorganization of actin cytoskeleton, cell mobility and adhesion. Other studies indicate that binding of integrins to the extracellular matrix proteins leads to PKC activation. In order to further investigate cellmatrix interactions (initial events of peptide binding to the annexin-V), PKC activation was studied. It is also unclear which is the initial domain of type II collagen that is involved in (N, C, and helical peptides) binding of the protein to the cell surface. The objective of this work was to characterize peptide interactions and its subsequent effects on the intracellular calcium levels and PKC activation.
What problem does this paper attempt to address?